Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at NEXTGEN HEALTHCARE INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. NEXTGEN HEALTHCARE INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. NEXTGEN HEALTHCARE INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
David A. Metcalfe
Former Executive Vice President and Chief Technology Officer
Total Cash $503,576 Equity $1,537,989 Other $26,328 Total Compensation $2,067,893
James R. Arnold Jr.
Executive Vice President and Chief Financial Officer
Total Cash $875,998 Equity $2,707,697 Other $42,189 Total Compensation $3,625,884
Jeffrey D. Linton
Executive Vice President and General Counsel and Secretary
Total Cash $625,976 Equity $974,787 Other $27,293 Total Compensation $1,628,056
Mitchell L. Waters
Executive Vice President of Commercial Growth
Total Cash $763,414 Equity $1,083,085 Other $14,583 Total Compensation $1,861,082
Srinivas Velamoor
Executive Vice President and Chief Growth Officer
Total Cash $829,770 Equity $2,436,933 Other $20,077 Total Compensation $3,286,780
David Sides
President and Chief Executive Officer
Total Cash $1,257,775 Equity $6,598,170 Other $39,876 Total Compensation $7,895,821
For its 2023 fiscal year, NEXTGEN HEALTHCARE INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
David Sides CEO Pay $7,895,821 Median Employee Pay $71,174 CEO Pay Ratio 111:1
For its 2023 fiscal year, NEXTGEN HEALTHCARE INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Craig Barbarosh Total Cash $295,773
Darnell Dent Total Cash $260,004
George Bristol Total Cash $285,004
Geraldine McGinty Total Cash $262,504
Jeffrey H. Margolis Total Cash $335,007
Julie D. Klapstein Total Cash $272,504
Morris Panner Total Cash $272,004
Pamela Puryear Total Cash $265,004

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.